World Health Organization (WHO) · Technical Documents
Interim recommendations for use of the inactivated COVID-19 vaccine BIBP developed by China National Biotec Group (CNBG), Sinopharm: interim guidance, first issued 7 May 2021, updated 28 October 2021, updated 15 March 2022
View original document
The full text is hosted by the publishing organisation. lawenc.com indexes the metadata and links to the official source.
Key facts
Organisation
World Health Organization (WHO)
Document type
Technical Documents
Source
World Health Organization